STOCKWATCH: How to hide the meaning of clinical data
This article was originally published in Scrip
Executive Summary
Investors like to be informed. So it is more than a little frustrating when public companies' clinical trial announcements omit important details; the way the trial was conducted, for instance, or the type of statistical analysis or the nature of the control with which a treatment was compared (scripintelligence.com, 16 July 2013).